Connection

William Groh to Humans

Back to Details
This is a "connection" page, showing publications William Groh has written about Humans.
William Groh
Connection Strength
0.533
Humans
  1. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. Heart Rhythm. 2022 10; 19(10):e61-e120.
    View in: PubMed
    Score: 0.031
  2. Myotonic Dystrophy and Conduction Disease. JACC Clin Electrophysiol. 2021 12; 7(12):1624.
    View in: PubMed
    Score: 0.030
  3. Rhythm management in myotonic dystrophy: Progress has been made, but unsettled issues remain. Heart Rhythm. 2018 07; 15(7):969-970.
    View in: PubMed
    Score: 0.024
  4. Arrhythmias in the muscular dystrophies. Card Electrophysiol Clin. 2015 Jun; 7(2):303-8.
    View in: PubMed
    Score: 0.019
  5. Change in cognitive function over 12 months among patients with an implantable cardioverter-defibrillator. J Cardiovasc Nurs. 2013 Nov-Dec; 28(6):E28-36.
    View in: PubMed
    Score: 0.017
  6. Arrhythmia management in myotonic dystrophy type 1. JAMA. 2012 Jul 25; 308(4):337-8; author reply 338.
    View in: PubMed
    Score: 0.016
  7. Arrhythmias in the muscular dystrophies. Heart Rhythm. 2012 Nov; 9(11):1890-5.
    View in: PubMed
    Score: 0.016
  8. You shouldn't take it with you: postmortem device reuse. Heart Rhythm. 2012 Feb; 9(2):215-6.
    View in: PubMed
    Score: 0.015
  9. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
    View in: PubMed
    Score: 0.015
  10. A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Heart Rhythm. 2012 Mar; 9(3):342-6.
    View in: PubMed
    Score: 0.015
  11. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve. 2011 May; 43(5):648-51.
    View in: PubMed
    Score: 0.015
  12. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.
    View in: PubMed
    Score: 0.014
  13. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J. 2010 Dec; 160(6):1137-41, 1141.e1.
    View in: PubMed
    Score: 0.014
  14. The electrocardiogram: a useful screening test for cardiac involvement in some but not all of the muscular dystrophies. Heart Rhythm. 2010 Oct; 7(10):1489-90.
    View in: PubMed
    Score: 0.014
  15. Validity and reliability of the chronic heart failure questionnaire mastery subscale in patients with defibrillators. West J Nurs Res. 2009 Dec; 31(8):1057-75.
    View in: PubMed
    Score: 0.013
  16. Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1. Muscle Nerve. 2009 Nov; 40(5):901-2.
    View in: PubMed
    Score: 0.013
  17. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs. 2009 Sep-Oct; 24(5):398-409.
    View in: PubMed
    Score: 0.013
  18. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008 Jun 19; 358(25):2688-97.
    View in: PubMed
    Score: 0.012
  19. Pacemaker/implantable cardioverter-defibrillator problem: right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator. Heart Rhythm. 2008 Jan; 5(1):158-9.
    View in: PubMed
    Score: 0.011
  20. Characteristics of volunteers responding to emergencies in the Public Access Defibrillation Trial. Resuscitation. 2007 Feb; 72(2):193-9.
    View in: PubMed
    Score: 0.011
  21. Lessons from a population: the limitations of left ventricular ejection fraction as the major determinant for primary prevention implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Mar 21; 47(6):1167-8.
    View in: PubMed
    Score: 0.010
  22. A reassuring call. Heart Rhythm. 2005 Aug; 2(8):842-3.
    View in: PubMed
    Score: 0.010
  23. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1. Muscle Nerve. 2005 Jun; 31(6):719-24.
    View in: PubMed
    Score: 0.010
  24. Factors associated with poor survival in women experiencing cardiac arrest in a rural setting. Heart Rhythm. 2005 May; 2(5):492-6.
    View in: PubMed
    Score: 0.010
  25. Come see the softer side of clinical outcomes: Quality-of-life measures in implanted defibrillator trials. J Cardiovasc Electrophysiol. 2004 Mar; 15(3):292-4.
    View in: PubMed
    Score: 0.009
  26. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004 Feb; 147(2):224-7.
    View in: PubMed
    Score: 0.009
  27. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1245-7.
    View in: PubMed
    Score: 0.009
  28. A comparison of first-responder automated external defibrillator (AED) application rates and characteristics of AED training. Prehosp Emerg Care. 2003 Oct-Dec; 7(4):453-7.
    View in: PubMed
    Score: 0.009
  29. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):227-32.
    View in: PubMed
    Score: 0.008
  30. Attitudes of law enforcement officers regarding automated external defibrillators. Acad Emerg Med. 2002 Jul; 9(7):751-3.
    View in: PubMed
    Score: 0.008
  31. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002 May; 13(5):444-8.
    View in: PubMed
    Score: 0.008
  32. Limited response to cardiac arrest by police equipped with automated external defibrillators: lack of survival benefit in suburban and rural Indiana--the police as responder automated defibrillation evaluation (PARADE). Acad Emerg Med. 2001 Apr; 8(4):324-30.
    View in: PubMed
    Score: 0.007
  33. Automated external defibrillators. N Engl J Med. 2001 Mar 08; 344(10):771-2; author reply 772-3.
    View in: PubMed
    Score: 0.007
  34. Cardiopulmonary resuscitation by chest compression alone. N Engl J Med. 2000 Sep 14; 343(11):815-6; author reply 816-7.
    View in: PubMed
    Score: 0.007
  35. Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy. J Am Heart Assoc. 2020 02 18; 9(4):e014006.
    View in: PubMed
    Score: 0.007
  36. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999 Oct; 10(10):1335-9.
    View in: PubMed
    Score: 0.007
  37. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation. 1999 Jul 27; 100(4):387-92.
    View in: PubMed
    Score: 0.006
  38. Software error resulting in malfunction of an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 1999 Jun; 10(6):871-3.
    View in: PubMed
    Score: 0.006
  39. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators. Am Fam Physician. 1998 Jan 15; 57(2):297-307, 310-2.
    View in: PubMed
    Score: 0.006
  40. Utility of Conventional Electrocardiographic Criteria in Patients With Idiopathic Ventricular?Tachycardia. JACC Clin Electrophysiol. 2017 07; 3(7):669-677.
    View in: PubMed
    Score: 0.006
  41. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996 Sep 15; 78(6):703-6.
    View in: PubMed
    Score: 0.005
  42. Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel. PLoS One. 2015; 10(12):e0143588.
    View in: PubMed
    Score: 0.005
  43. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation. 2015 May 05; 131(18):1590-8.
    View in: PubMed
    Score: 0.005
  44. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55.
    View in: PubMed
    Score: 0.004
  45. A pilot study in hemodialysis of an electrophysiological tool to measure sudden cardiac death risk. Clin Nephrol. 2007 Sep; 68(3):159-64.
    View in: PubMed
    Score: 0.003
  46. Adverse events associated with lay emergency response programs: the public access defibrillation trial experience. Resuscitation. 2006 Jul; 70(1):59-65.
    View in: PubMed
    Score: 0.003
  47. ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? J Am Coll Cardiol. 2006 Apr 04; 47(7):1339-45.
    View in: PubMed
    Score: 0.003
  48. Implementation of community-based public access defibrillation in the PAD trial. Acad Emerg Med. 2005 Aug; 12(8):688-97.
    View in: PubMed
    Score: 0.002
  49. Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. Nucl Med Biol. 2004 Oct; 31(7):957-64.
    View in: PubMed
    Score: 0.002
  50. Measuring survival rates from sudden cardiac arrest: the elusive definition. Resuscitation. 2004 Jul; 62(1):25-34.
    View in: PubMed
    Score: 0.002
  51. Law Enforcement Agency Defibrillation (LEA-D): proceedings of the National Center for Early Defibrillation Police AED Issues Forum. Prehosp Emerg Care. 2002 Jul-Sep; 6(3):273-82.
    View in: PubMed
    Score: 0.002
  52. Law Enforcement Agency Defibrillation (LEA-D): position statement and best practices recommendations from the National Center for Early Defibrillation. Prehosp Emerg Care. 2002 Jul-Sep; 6(3):346-7.
    View in: PubMed
    Score: 0.002
  53. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000 Dec; 36(7):2247-53.
    View in: PubMed
    Score: 0.002
  54. Radiofrequency catheter ablation for postinfarct ventricular tachycardia. Curr Opin Cardiol. 1999 Jan; 14(1):30-5.
    View in: PubMed
    Score: 0.002
  55. Atrial macroreentry involving the myocardium of the coronary sinus: a unique mechanism for atypical flutter. J Cardiovasc Electrophysiol. 1998 Oct; 9(10):1094-9.
    View in: PubMed
    Score: 0.002
  56. Bilateral internal mammary-to-pulmonary artery fistulas after a coronary operation. Ann Thorac Surg. 1994 Jun; 57(6):1642-3.
    View in: PubMed
    Score: 0.001
  57. [5-years experience with pacemaker therapy]. Orv Hetil. 1971 Aug 22; 112(34):2007-10.
    View in: PubMed
    Score: 0.001
  58. Sonographic measurement of gallbladder volume. AJR Am J Roentgenol. 1985 Nov; 145(5):1009-11.
    View in: PubMed
    Score: 0.001
  59. Data base management system for tracking occupational health. Am Ind Hyg Assoc J. 1983 Jun; 44(6):389-94.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.